Forget a Cash ISA! I’d invest in these 2 FTSE 100 shares today to make a million

I think these two FTSE 100 (INDEXFTSE:UKX) shares could offer high returns due, in part, to their low valuations.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Opening a Cash ISA could lead to long-term disappointment. Even the best rates available are lower than inflation, which means the spending power of your capital may fall over the long run.

By contrast, the FTSE 100 offers a relatively high dividend yield of over 4%. The index could also deliver impressive levels of capital growth, with its track record showing it’s likely to overcome the near-term risks currently faced.

As such, now could be the right time to invest in these two FTSE 100 stocks. They could offer high returns that ultimately improve your prospects of making a million in the long run.

GSK

The prospects for pharmaceutical companies, such as GSK (LSE: GSK), could improve over the coming years. A number of factors, such as an ageing world population and increasing urbanisation, may contribute to increasing demand for the company’s products. This could lead to a potential tailwind for the business as it embarks on a more focused strategy that has seen it dispose of a number of major consumer healthcare brands.

In addition, GSK may become a more popular stock among investors due to its relatively low correlation with the wider economy. At a time when investors are fearful about events such as Brexit, US political risks, and a global trade war, healthcare companies may seem to be a resilient means of generating growth.

With a price-to-earnings (P/E) ratio of 14.5, the company appears to offer good value for money compared to its sector peers. Its dividend yield of 4.6% is roughly in line with the wider index, but could grow at a fast pace due to favourable operating conditions over the coming years.

Compass Group

The financial performance of support services company Compass Group (LSE: CPG) over recent years has been highly impressive, as well as consistent. It has recorded an annualised rise in net profit of over 10% in the last five years, delivering growth in every year during the period.

Its consistent performance could attract investors who are looking for increasingly dependable returns during a period where global economic risks are heightened. Compass Group is forecast to record a rise in net profit of 9% in the current year, which suggests that its overall strategy is working well.

The company continues to make bolt-on acquisitions that could enhance its financial outlook. Its financial position suggests that there’s scope for it to engage in further M&A activity, while its recent strong performance in the US could continue as it seeks to widen margins in many of its key markets.

From a long-term risk/reward perspective, Compass Group appears to have strong appeal. It could offer a mix between impressive growth and relatively resilient returns that increases your chances of generating a seven-figure portfolio.

Peter Stephens owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Compass Group. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

How can we get started building a passive income ISA in 2026?

Didn't an ancient Chinese investor say the journey to a passive income fortune begins with a single step? If they…

Read more »

Investing Articles

Seeking New Year bargains? FTSE 100 index shares remain on sale!

These FTSE 100 index stocks have surged in value in 2026. But they still offer plenty for value investors to…

Read more »

Landlady greets regular at real ale pub
Investing Articles

Will the crashed Diageo share price rebound 63% in 2026?

Diageo's share price has collapsed by more than a third since 1 January. But these brokers expect the FTSE 100…

Read more »

Happy young female stock-picker in a cafe
Investing Articles

1 top investment trust to consider from the FTSE 250 

This niche FTSE 250 investment trust offers exposure to one of Asia's fastest growing economies, potentially setting it up for…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

2 high risk/high reward stock market picks to consider in 2026

The coming year could bring about lots of stock market opportunities for brave investors willing to stomach risk. Mark Hartley…

Read more »

Investing Articles

ChatGPT thinks these are the 5 best FTSE stocks to consider buying for 2026!

Can the AI bot come up trumps when asked to select the best FTSE stocks to buy as we enter…

Read more »

Investing For Beginners

How much do you need in an ISA to make the average UK salary in passive income?

Jon Smith runs through how an ISA can help to yield substantial income for a patient long-term investor, and includes…

Read more »

Investing Articles

3 FTSE 250 shares to consider for income, growth, and value in 2026!

As the dawn of a new year in the stock market approaches, our writer eyes a trio of FTSE 250…

Read more »